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Abstract: Higher daily protein intake, with an emphasis on leucine content, is thought to mitigate
age-related anabolic resistance, potentially counteracting age-related morphological and functional
declines. The present study investigated potential associations between total daily leucine intake
and dependent variables, including quadriceps muscle cross-sectional area (CSA) and maximum
dynamic muscle strength (1-RM) in a cohort of healthy free-living older individuals of both sexes
(n = 67; 34/33 men/women). Participants performed three 24 h dietary recalls and underwent a
magnetic resonance imaging exam followed by 1-RM tests. Our results demonstrate moderate
associations between total daily leucine and both quadriceps CSA (r = 0.42; p = 0.004) and 1-RM
(r = 0.45; p = 0.001). Furthermore, our exploratory biphasic linear regression analyses, adjusted for
sex, age, and protein intake relative to body weight, revealed a plateau for daily leucine intake and
muscle mass and muscle strength (~7.6–8.0 g·day−1) in older adults. In conclusion, we demonstrated
that total daily leucine intake is associated with muscle mass and strength in healthy older individuals
and this association remains after controlling for multiple factors, including overall protein intake.
Furthermore, our breakpoint analysis revealed non-linearities and a potential threshold for habitual
leucine intake, which may help guide future research on the effects of chronic leucine intake in
age-related muscle loss.
Keywords: protein intake; aging; muscle function; essential amino acids; older individuals
1. Introduction
Skeletal muscle mass is regulated by daily fluctuations in muscle protein synthesis
(MPS) and breakdown (i.e., net protein balance). Aging, however, is known to disrupt net
protein balance, blunting the MPS response to anabolic stimuli, such as exercise and protein
intake (i.e., age-related anabolic resistance) [1–4]. These changes result in the loss of skeletal
muscle mass [5], which is accompanied by decreases in functionality, independence, quality
of life, and health span [6–8].
It has been proposed that a higher protein intake may help older individuals overcome
age-related anabolic resistance, possibly mitigating losses in muscle mass and function [9].
Leucine content within a protein is of the utmost importance to anabolic stimulation,
as it is thought to exert a pivotal role in MPS stimulation [10,11]. Devries et al. [10]
Nutrients 2021, 13, 3536. https://doi.org/10.3390/nu13103536 https://www.mdpi.com/journal/nutrients
Nutrients 2021, 13, 3536 2 of 7
demonstrated that a higher leucine concentration per meal (4.2 g) potentiated MPS, as
compared with lower doses (1.3 g) in older adults, despite a similar bolus of total protein
(15 g). Similarly, Murphy et al. [11] demonstrated that adding leucine to the regular meals
of older individuals also increased MPS.
Despite the existing data supporting the potential benefits of higher leucine consump-
tion during aging, international recommendations do not account for the effects of age-
related anabolic resistance [12]. Nonetheless, recently, Szwiega et al. [13] estimated—using
an acute infusion protocol based on an indicator amino acid oxidation technique—that
the leucine requirement for older adults is more than double that of younger individuals
(~78 versus 35 mg·kg−1·day−1, respectively). These results provide valuable insight, but
they may be limited by a small sample size and well-controlled experimental conditions,
which may not always precisely predict or correlate with neuromuscular outcomes [14,15].
In free-living conditions, dietary habits vary between individuals, providing an opportu-
nity to use observational data to gather further insight into the possible effects of daily
leucine consumption on muscle mass and function in older individuals.
Thus, this study aimed to investigate the potential impact of habitual total daily leucine
intake on quadriceps muscle cross-sectional area (CSA) and maximum dynamic muscle
strength (1-RM) in a cohort of healthy free-living older individuals. It was hypothesized
that a cross-sectional analysis of leucine intake would demonstrate positive relationships
with both morphological and functional outcomes.
2. Materials and Methods
2.1. Participants
Sixty-seven healthy elderly individuals of both sexes (34/33 men/women; age: 69.71 ± 4.04/
69.36 ± 4.25 years men/women; body mass index: 26.45 ± 3.34/ 26.70 ± 4.57 kg·m2−1 men/
women; quadriceps muscle cross-sectional area: 53.89 ± 13.00 cm2; unilateral maximum dy-
namic muscle strength: 46.38 ± 19.37 kg) participated in the study. Out of the entire sample,
24.32% presented with controlled hypertension (i.e., blood pressure within limits (<140/90 mm
Hg) via medication) and 20.27% presented with controlled dyslipidemia (i.e., fasting lipids
within limits (cholesterol: <200 mg·dl−1; triglycerides: <150 mg·dl−1; LDL: 130 mg·dl−1 and/or;
HDL >35 mg·dl−1) via medication). Participants’ dietary intakes are presented in Table 1. Partic-
ipants were not engaged in any kind of regular resistance training and/or aerobic training for
at least six months prior to the experimental period. All participants provided their informed
consent before enrolling in the study. The experimental protocol was approved by the local
University’s Research Ethics Committee (CAEE: 62590416.0.0000.5391).















Men 2192.1 ± 660.7 87.3 ± 22.5 1.1 ± 0.3 6650.2 ± 1928.4 86.2 ± 24.1 283.4 ± 104.9 75.6 ± 27.6
Women 1670.0 ± 516.2 67.35 ± 24.0 1.0 ± 0.4 4356.7 ± 1457.6 72.3 ± 23.6 217.3 ± 64.0 57.8 ± 24.3
Total 1938.2 ± 641.2 77.5 ± 25.0 1.1 ± 0.3 5666.9 ± 1975.1 79.4 ± 24.7 251.7 ± 89.8 67.6 ± 27.6
Data are presented as mean standard deviation; g: grams; mg: milligrams; kg: kilograms; CHO: carbohydrates.
2.2. Dietary Assessment
Participants performed three 24 h dietary recalls (2 non-consecutive weekdays and
1 weekend day) to determine habitual daily protein/leucine intake, using the USDA
Automated Multiple-Pass Method [16]. A trained nutritionist gave oral and written
instructions on how to perform the dietary recalls, including timing and estimation of
portion size using household measures on an individual basis [17,18]. Upon retrieval,
the same nutritionist checked the dietary recall using a visual album with real photos
of foods to confirm the accuracy of the estimated portions by participants [19]. Data
were analyzed with specific software (Nutritionist Pro version 7.3, Axxya Systems,
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Woodinville, WO, USA). Variables of interest were extracted from the software and are
expressed either as total grams per day (g·day−1) or total grams normalized to kilograms
of body mass per day (g·kg−1·d−1) (Table 1).
2.3. Quadriceps Muscle Cross-Sectional Area (CSA)
The quadriceps muscle cross-sectional area (CSA) of both legs was obtained through
magnetic resonance imaging (MRI) (Sigma LX 9.1, GE Healthcare, Milwaukee, WI, USA).
The image was acquired at 50% of the segment length (middle point between the greater
trochanter to the inferior border of the lateral epicondyle of the femur) in 8 mm slices for
3 s. The pulse sequence was performed with a view field between 400 and 420 mm, a
time repetition of 350 ms, an echo time from 9 to 11 ms, two signal acquisitions, and a
matrix reconstruction of 256 × 256. The quadriceps CSA was measured by computerized
planimetry (i.e., the region of interest was contoured following the muscle fascia) (ImageJ,
version 1.53c, National Institutes of Health, Bethesda, MD, USA). The within-researcher
measurement error was < 1% (i.e., same MRI image measurement with 72 h interval) [20].
2.4. Unilateral Maximum Dynamic Muscle Strength
The unilateral maximum dynamic muscle strength of both legs was assessed using
the 1-RM test on a leg-extension machine (Movement technology, Burden, Sao Paulo,
Brazil) following previous recommendations [21]. Upon the first visit, participants were
familiarized with the 1-RM test. After 48 h, participants performed two 1-RM test sessions
interspaced by 72 h. If any participant had a difference higher than 5% between 1-RM tests,
an additional session was performed. The protocol consisted of a 5 min general warm-up
on a cycle ergometer (Movement technology, Burden, Sao Paulo, Brazil). This procedure
was followed by a specific warm-up with submaximal loads (i.e., 8 repetitions at 50% and
3 repetitions at 80% of the estimated 1-RM). The rest interval between warm-up sets was
1 min. After a 3 min resting period, participants had up to five attempts to achieve their
1-RM, and a 3 min rest interval was allowed between attempts.
2.5. Statistical Analyses
Correlation (Pearson coefficient) and regression-based analyses were conducted to
quantify the relationships between total daily leucine intake (g·day−1) and two dependent
variables, including a morphological (average bilateral quadriceps CSA) and functional
(average bilateral 1-RM) outcome. Based on previous research suggesting non-linear rela-
tionships between protein/leucine content and outcomes [9,13], both linear regression and
biphasic linear regression including a breakpoint (upper threshold with the second slope
set to zero) were included. To control for potential confounding, the regression models
also included sex, age, and total daily protein normalized to body weight (g·kg−1·d−1).
Pearson’s correlation coefficients were calculated between independent and dependent
variables and between each independent variable, ensuring all values were below 0.7 (anal-
ysis identified r < |0.65|) to reduce the potential for multicollinearity. Model comparison
(biphasic versus simple linear regression) was completed via a likelihood ratio test and
the appropriate standard chi-squared asymptotic reference distribution. An a priori alpha
of 0.05 was used as a decision rule to define compatibility/incompatibility between each
hypothesis and the data (given the model used to generate each p value). Analyses were
performed in R statistical software (Version 3.6.3, R Foundation for Statistical Computing,
Vienna, Austria) and Rstudio (Version 1.4.1103, Rstudio, Inc., Boston, MA, USA). Data are
presented as mean ± standard deviation, unless otherwise stated.
3. Results
There was a moderate and positive association between total daily leucine intake
(g·day−1) and both quadriceps CSA (r = 0.42; p < 0.001) and 1-RM (r = 0.45; p < 0.001).
Accounting for sex, age, and relative protein intake increased the uncertainty in the asso-
ciation between total daily leucine intake and both quadriceps CSA (β = 1.7, p = 0.051)
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and 1-RM (β = 2.4, p = 0.053). Significant improvements in overall model fit were ob-
tained with biphasic linear regression for both quadriceps CSA (χ2 = 4.7, p = 0.030) and
1-RM (χ2 = 5.1, p = 0.023). For quadriceps CSA, a significant and positive association was
obtained with total daily leucine intake (β = 3.0, p = 0.003), with an estimated breakpoint
of 7.6 g·day−1 (95%CI: 6.5–8.7; Figure 1). Similarly, a significant positive association was
obtained with 1-RM and total daily leucine intake (β = 4.2, p = 0.005), with an estimated
breakpoint of 8.0 g·day−1 (95%CI: 6.9–9.1; Figure 1).
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4. Discussion
The present study employed a cross-sectional design to investigate the relationship
between total daily leucine intake and morphological (quadriceps CSA) and functional
(1-RM) muscular parameters in free-living healthy sedentary older individuals. Our results
demonstrated moderate positive correlations between total daily leucine intake and both
quadriceps CSA and 1-RM. These results may be of clinical relevance, as lower-body muscle
groups seem to be more negatively affected by the biological process of aging [22], and
higher habitual leucine intake may serve as a potential countermeasure to these age-related
decrements. Furthermore, our exploratory biphasic linear regression analysis, adjusted
for confounding factors, revealed non-linearities and a potential plateau for daily leucine
intake and muscle mass and muscle strength (~7.6–8.0 g·day−1) in older adults.
Age-related anabolic resistance to protein intake seems to be mediated by the increased
splanchnic retention of proteins [23,24], as well as a reduced blood flow to musculature [25],
reducing the availability of amino acids (AAs) into muscle cells. Deprivation of AAs,
namely leucine, is thought to impair the phosphorylation of the mechanistic target of
rapamycin complex 1 (mTORC1)—a pivotal pathway linked to anabolic responses (i.e.,
increases in MPS). The impaired anabolic response to feeding partially accounts for losses
in skeletal muscle mass and strength during aging [5]. However, higher protein intake [9],
with increased amounts of leucine [26,27], seems to mitigate this phenomenon. Acute and
short-term trials (up to 2 weeks) with leucine supplementation (3–4 g per meal) in older
adults have shown robust increases in MPS [11,27–29]; thus, suggesting that leucine could
be used as a non-pharmacological strategy to counteract muscle wasting and functional
declines during aging.
Based on appealing acute findings of leucine supplementation, observational data
analyses have investigated the protective effects of habitual leucine intake on morphological
and functional outcomes during aging [30,31]. Chae et al. [30] observed a positive and
significant correlation between leucine intake and muscle mass index in healthy middle-
aged non-obese individuals (50–64 years). Similar results were observed in an older cohort
(>65 years), with a significant correlation between leucine intake and handgrip strength [31].
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Besides corroborating with previous reports, our results expand the literature by showing
the importance of leucine intake for muscle mass in individuals above 65 years. It could be
speculated that consuming higher amounts of leucine daily increases its availability within
the muscle, potentiating MPS in older individuals. Altogether, these results reinforce the
notion that adequate leucine intake may protect against age-related muscle wasting and its
concomitant functional declines.
Despite this, leucine recommendations specifically tailored for older adults are
still scarce. To shed further light on the topic, we used a breakpoint approach in our
retrospective dataset using individuals in free-living conditions. Our results yield an
estimated breakpoint of 7.6 g·day−1 of leucine for muscle mass. In addition, our results
expand on previous findings, as we also observed a breakpoint for lower limb muscle
strength (8.0 g·day−1 of leucine). These data indicate that even in non-laboratory-based
experimental conditions, the association between habitual leucine intake and morpholog-
ical and functional outcomes follows a somewhat daily saturable dose–response pattern.
In a related study, Szwiega et al. [13] estimated, using the indicator amino acid oxidation
(IAAO) method, that older adults’ requirements for leucine may be higher than the
current recommendation (~78 mg·kg−1·day−1 vs. 34–39 mg·kg−1·day−1). However,
this estimation does not directly relate to the amount of leucine needed to maximally
stimulate the rates of MPS. This notion is corroborated by the higher value for the break-
point of leucine intake observed in our study (7.6–8.0 g·day−1, which is equivalent to
~110–115 mg·kg−1·day−1), and those observed by acute studies investigating the impact
of additional leucine intake on integrated 3-day rates of MPS (~20–23 g·day−1, which is
equivalent to ~240–280 mg·kg−1·day−1) [11]. Collectively, data from Szwiega et al. [13]
and Murphy et al. [11], and our exploratory data analysis suggest potential cutoffs
that can be used to titrate leucine requirements for older adults targeting muscle mass
preservation and serve as guidance for future clinical trials aiming to test these values in
a clinical setting.
This study is not without limitations. We estimated total daily leucine intake based on
dietary recalls, which, despite our robust control of the method, may be prone to over- or
under-reporting dietary intake. The sample size may be considered small for observational
data analyses; however, based on the significant correlations observed herein, we posit that
our results hold clinical value. Finally, our study design precludes inferring cause–effect
relationships. Previous prospective randomized controlled trials have failed to demonstrate
the effects of leucine supplementation associated [32,33] or not [34,35] with exercise in
promoting gains in muscle mass or mitigating age-related muscle loss. Notably, none of
these studies provided additional protein in their dietary intervention, which has proven to
be critical in overcoming the anabolic resistance of aging. This suggests that, in the clinical
setting, supplementary leucine alone (without increasing total protein intake) may not be
sufficient to elicit a positive net protein balance, especially in more vulnerable individuals,
such as the pre-frail or frail elderly [32]. Given that muscle wasting is a slow, degenerative
process, longer-term trials are warranted to validate the potential beneficial role of leucine,
via diet or supplementation, in aging individuals.
5. Conclusions
We demonstrated that total daily leucine intake is associated with muscle mass and
strength in healthy older individuals. Furthermore, our breakpoint analysis revealed non-
linearities and a potential threshold for habitual leucine intake, which may help guide
clinical nutritional practice aimed at mitigating the morphological and functional declines
associated with aging. Randomized controlled trials should test the utility of additive
leucine to counteract frailty in the elderly.
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